Contezolid
- Generic Name
- Contezolid
- Indication
用于治疗由对本品敏感的金黄色葡荷球菌（甲氧西林敏感和耐药的菌株，包括MRSA）、化脓性链球菌或无乳链球菌引起的复杂性皮肤和软组织感染。
为减少细菌耐药的发生，确保康替唑胺及其他抗菌药物的疗效，本品应仅用于治疗已确诊或高度怀疑由敏感菌引起的感染。本品不适用于治疗革兰阴性菌感染。如确诊或怀疑合并有革兰阴性菌感染，建议联合应用抗革兰阴性菌药物进行治疗
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06811012
- Locations
- 🇨🇳
Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, Beijing, China
Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06811025
- Locations
- 🇨🇳
Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, Beijing, China
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Conditions
- Pulmonary TuberculosisRifampicin-resistant Tuberculosis
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 186
- Registration Number
- NCT06081361
- Locations
- 🇨🇳
Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China
🇨🇳People's Hospital of Linyi, Linyi, China
🇨🇳Fourth People's Hospital of Nanning, Nanning, China
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
- Conditions
- Diabetic Foot Infection
- Interventions
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- MicuRx
- Target Recruit Count
- 865
- Registration Number
- NCT05369052
- Locations
- 🇺🇸
New Hope Research Development, Corona, California, United States
🇺🇸Clemente Clinical Research, Los Angeles, California, United States
🇺🇸VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
- Conditions
- Skin Diseases, BacterialGram-Positive Bacterial Infections
- Interventions
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- MicuRx
- Target Recruit Count
- 196
- Registration Number
- NCT03747497
- Locations
- 🇺🇸
MicuRx Site #107, Butte, Montana, United States
🇺🇸MicuRx Site #106, Chula Vista, California, United States
🇺🇸MicuRx Site #103, La Mesa, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.